Status:
WITHDRAWN
Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
25+ years
Phase:
PHASE3
Brief Summary
To assess the impact of Duloxetine and Imipramine on therapeutic efficacy, psychological distress, sexual function, bladder wall structure and blood flow in women
Detailed Description
To assess the impact of Duloxetine and Imipramine on therapeutic efficacy, psychological distress, sexual function, bladder wall structure and blood flow in women
Eligibility Criteria
Inclusion
- \- Stress urinary incontinence
Exclusion
- Take monoamine oxidase
- Myocardial infarction critical,cardiovascular insufficiency (such as room blocking, arrhythmia, blood-soaked heart failure, myocardial infarction, stroke and excessive heartbeat).
- Allergy to duloxetine or imipramine
- Uncontrolled angular glaucoma patients
- Pregnant women
Key Trial Info
Start Date :
May 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04412876
Start Date
May 31 2020
End Date
June 3 2021
Last Update
August 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan, 22050